Pacira BioSciences, Inc. (PCRX) Social Stream
PACIRA BIOSCIENCES INC (PCRX) Price Targets From Analysts
Use the tables below to see what analysts covering PACIRA BIOSCIENCES INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 12 | $93 | $54 | $80.916 | $39.33 | 105.74% |
| 2021-12-08 | 12 | $93 | $54 | $81.083 | $39.33 | 106.16% |
| 2021-12-10 | 13 | $97 | $54 | $81.416 | $39.33 | 107.01% |
| 2022-01-07 | 13 | $97 | $54 | $81.538 | $39.33 | 107.32% |
| 2022-01-13 | 13 | $97 | $54 | $81.846 | $39.33 | 108.1% |
| 2022-02-25 | 13 | $97 | $54 | $82.153 | $39.33 | 108.88% |
| 2022-03-01 | 13 | $96 | $54 | $82.333 | $39.33 | 109.34% |
| 2022-04-14 | 11 | $96 | $54 | $81.363 | $39.33 | 106.87% |
| 2022-05-05 | 11 | $96 | $54 | $81.6 | $39.33 | 107.48% |
| 2022-05-13 | 10 | $96 | $54 | $81.6 | $39.33 | 107.48% |
| 2022-06-01 | 9 | $96 | $54 | $83.222 | $39.33 | 111.6% |
| 2022-06-15 | 8 | $96 | $54 | $83.125 | $39.33 | 111.35% |
| 2022-07-21 | 8 | $96 | $54 | $81.625 | $39.33 | 107.54% |
| 2022-08-01 | 8 | $96 | $54 | $81.125 | $39.33 | 106.27% |
| 2022-08-02 | 8 | $96 | $54 | $80.75 | $39.33 | 105.31% |
| 2022-08-04 | 8 | $96 | $54 | $80.142 | $39.33 | 103.77% |
| 2022-09-21 | 8 | $96 | $54 | $80.125 | $39.33 | 103.72% |
| 2022-10-13 | 7 | $96 | $54 | $80.125 | $39.33 | 103.72% |
| 2022-10-17 | 7 | $96 | $54 | $79.25 | $39.33 | 101.5% |
| 2022-11-02 | 8 | $96 | $54 | $77.777 | $39.33 | 97.75% |
| 2022-11-04 | 9 | $96 | $54 | $75.333 | $39.33 | 91.54% |
| 2022-11-15 | 9 | $96 | $54 | $73.5 | $39.33 | 86.88% |
| 2022-12-21 | 9 | $96 | $50 | $73.1 | $39.33 | 85.86% |
| 2023-01-05 | 9 | $96 | $50 | $70.555 | $39.33 | 79.39% |
| 2023-01-06 | 9 | $96 | $50 | $68.444 | $39.33 | 74.02% |
| 2023-01-17 | 9 | $88 | $50 | $64.375 | $39.33 | 63.68% |
| 2023-01-31 | 9 | $76 | $50 | $60.875 | $39.33 | 54.78% |
| 2023-02-10 | 9 | $69 | $50 | $60 | $39.33 | 52.56% |
| 2023-02-14 | 9 | $69 | $50 | $59.5 | $39.33 | 51.28% |
| 2023-03-01 | 10 | $76 | $50 | $60.666 | $39.33 | 54.25% |
The Trend in the Analyst Price Target
Over the past 18 months, PCRX's average price target has gone down $18.33.
PCRX reports an average of 48.01% for its upside potential over the past 46 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-05-05 | 11 | 96 | 54 | 81.600 | 63.93 | 27.64% |
| 2022-06-01 | 9 | 96 | 54 | 83.222 | 63.45 | 31.16% |
| 2022-06-15 | 8 | 96 | 54 | 82.125 | 54.55 | 50.55% |
| 2022-08-01 | 8 | 96 | 54 | 81.125 | 56.18 | 44.4% |
| 2023-02-14 | 9 | 69 | 50 | 59.500 | 40.55 | 46.73% |
PCRX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.6 | 6 | 2 | 2 | 0 | 0 | 10 |
The Trend in the Broker Recommendations
Over the past 15 months, PCRX's average broker recommendation rating improved by 0.07.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- PACIRA BIOSCIENCES INC's average analyst price target is higher than 3150.08% of Pharmaceutical Products stocks.
- PCRX has a greater number of analysts covering the stock than 2826.19% of stocks in the mid market cap category.
- In the context of stocks in the mid market cap category, PACIRA BIOSCIENCES INC's upside potential (average analyst target price relative to current price) is higher than 2724.01% of them.
- In terms of how PACIRA BIOSCIENCES INC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than -1330.13% of that group.
In the Pharmaceutical Products industry, EBS, SUPN, and PBH are the three stocks most similar to PACIRA BIOSCIENCES INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding PCRX using the data that counts. Try POWR Ratings for free.